Agentia for treating infantile autism

A technology of autism and medicine, which is applied in the field of medicine for the treatment of children with autism, achieving good safety and clear curative effect

CN104306776AInactive Publication Date: 2015-01-28张士香
0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Publication Date
2015-01-28
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

The invention relates to agentia for treating infantile autism. The agentia is prepared from the following substances according to a weight ratio: taxillus delavayi, bilobate grewia, lombardy poplar, ciliate leucas herb, bamboo fungus, spurless columbine root or herb, smallflower pellitory root, arrowroot, contorted tanglehead herb, pilea notata, pyrrosia lingua, mushroom, common calanthe herb and creeper. As all ingredients of the agentia are natural materials, the agentia for treating infantile autism, provided by the invention, has the advantages of better safety and definite effect and is suitable for large-scale clinical promotion.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention is a divisional application of an invention patent with the application number 201310573706.2, the application date is November 15, 2013, and the invention title is "a medicament for treating autism in children". technical field

[0002] The invention relates to the field of child care, in particular to a medicament for treating children with autism. Background technique

[0003] Medically, autism is called autism, which is a typical pervasive developmental disorder in children. Clinical psychology believes that children with autism often involve language, cognition, social skills and other psychological developmental disorders, usually onset around 3 years old, manifested as social ability impairment, language development impairment, rigid behavior and narrow interests Wait. According to WHO reports, the global incidence of autism in children is between 0.02% and 0.2%, and in my country it is between 0.03% and 0.10%. , which adversely affects t...

Examples

Embodiment

[0009] Embodiment Decoction of the present invention

[0010] Weigh 6 grams of willow parasitism, 3 grams of baby boxer, 5 grams of Zhuantian poplar, 8 grams of hydrangea Fangfeng, 9 grams of bamboo fungus, 3 grams of wild peucedanum, 6 grams of wall grass root, 3 grams of arrowroot, 6 grams of ground tendon, and 3 grams of cold water flower gram, 6 grams of Yizhiqi, 8 grams of shiitake mushrooms, 5 grams of Cynthia chinensis and 2 grams of Sanjiao Jinlong, add 8000 ml of water, heat in a flask equipped with a condenser at 80°C for 6 hours, filter, and the filtrate is Decoction of the present invention.

experiment example

[0012] normal information

[0013] 48 cases of children with autism were selected and treated, including 36 males and 12 females; 17 cases aged 1-3 years, 21 cases aged 3-5 years, 10 cases aged 5-9 years, with an average age of 5.51 years; months - 6 years, with an average of 3.78 years.

[0014] Diagnostic criteria

[0015] According to the diagnostic criteria of autism in infants and young children in the "Diagnostic and Statistical Booklet of Mental Disorders". The specific implementation standards are: ① meet the above criteria; ② age under 10 years old; ③ voluntarily accept this trial, and can persist in taking medicine and nursing care for 6 months; ④ no concurrent history of schizophrenia, selective mutism, epilepsy; ⑤ The family members agreed to take the medicine and signed the informed consent.

[0016] treatment method

[0017] Use the decoction prepared in Example 1 to treat. 1 time a day, 50 ml orally each time, continuous treatment for 24 weeks.

[0018] Ef...